Back
Scilex Holding Vs. Oramed Pharmaceuticals Industry Stock Comparison
Sell
43
SCLX
Scilex Holding
Last Price:
0.68
Seasonality Move:
-3.66%
Sell
39
ORMP
Oramed Pharmaceuticals
Last Price:
2.33
Seasonality Move:
22.85%
Sell
43
Scilex Holding (SCLX)
is a Sell
Is Scilex Holding a Buy, Sell or Hold?
- The current Scilex Holding [SCLX] share price is $0.74. The Score for SCLX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- SCLX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Oramed Pharmaceuticals (ORMP)
is a Sell
Is Oramed Pharmaceuticals a Buy, Sell or Hold?
- The current Oramed Pharmaceuticals [ORMP] share price is $2.33. The Score for ORMP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ORMP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SCLX Stock Price Chart
What is Scilex Holding's stock price today?
-
The Scilex Holding share price today is $0.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SCLX is experiencing selling pressure, which indicates risk of future bearish movement.
ORMP Stock Price Chart
What is Oramed Pharmaceuticals's stock price today?
-
The Oramed Pharmaceuticals share price today is $2.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORMP is experiencing slight buying pressure.
SCLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 35.21 | Sell |
| Chaikin Money Flow: | -1063981 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.82 - 1) | Sell |
| Bollinger Bands (100): | (0.86 - 1.6) | Sell |
ORMP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 46.77 | Sell |
| Chaikin Money Flow: | -8376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.33 - 2.39) | Sell |
| Bollinger Bands (100): | (2.32 - 2.52) | Sell |
SCLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.91 | Sell |
| 20-day SMA: | 0.93 | Sell |
| 50-day SMA: | 0.93 | Sell |
| 200-day SMA: | 1.29 | Sell |
| 8-day EMA: | 0.86 | Sell |
| 20-day EMA: | 0.9 | Sell |
| 50-day EMA: | 0.98 | Sell |
| 200-day EMA: | 1.5 | Sell |
ORMP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.34 | Sell |
| 20-day SMA: | 2.35 | Sell |
| 50-day SMA: | 2.38 | Sell |
| 200-day SMA: | 2.52 | Sell |
| 8-day EMA: | 2.34 | Sell |
| 20-day EMA: | 2.35 | Sell |
| 50-day EMA: | 2.37 | Sell |
| 200-day EMA: | 2.51 | Sell |
Scilex Holding Earnings Growth & SCLX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.10 per share.
Oramed Pharmaceuticals Earnings Growth & ORMP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and a decrease next year of $0.43 per share.
Scilex Holding Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oramed Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||